CM

Chamanlal Mohanlal Bhanvadia

Active Director Director DIN 11363614
DIN 11363614 First appointment Nov 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Chamanlal Mohanlal Bhanvadia

Data last updated:

Chamanlal Mohanlal Bhanvadia is a Director at Jorvedis Pharma Private Limited (since 2025).

DIN 11363614
Primary Designation Director
First Appointment 01 Nov 2025

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Jorvedis Pharma Private Limited U21000GJ2025PTC166144
Director01 Nov 2025Active

Directorship timeline

Open interactive timeline →
Jorvedis Pharma Private Limited
Premium access

Shareholding and investment profile for Chamanlal Mohanlal Bhanvadia

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chamanlal Mohanlal Bhanvadia

Chamanlal Mohanlal Bhanvadia currently holds 1 directorship: Jorvedis Pharma Private Limited (Director, since 01 Nov 2025).

Chamanlal Mohanlal Bhanvadia was first appointed on 01 Nov 2025 as Director at Jorvedis Pharma Private Limited.

The current boards of Chamanlal Mohanlal Bhanvadia's companies include Haresh Bachubhai Chudasama (Jorvedis Pharma Private Limited), Patel Minakshiben (Jorvedis Pharma Private Limited), Rajesh Vinodkumar Ghanshani (Jorvedis Pharma Private Limited), Ronakkumar Mahendrabhai Patel (Jorvedis Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available